From February 10, 2014 to March 31, 2014, the company has repurchased 162,147 shares, representing 2.24% for KRW 934.3 million. With this, the company has completed the repurchase of 162,147 shares, representing 2.24% for KRW 934.3 million under the buyback announced on February 10, 2014.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26,200 KRW | +5.01% | +3.15% | +1.35% |
2023 | NeoPharm CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2019 | NeoPharm CO., LTD. announced that it has received KRW 31.970667276 billion in funding | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.35% | 144M | |
+0.63% | 265B | |
+20.31% | 20.59B | |
+14.35% | 12.22B | |
-11.59% | 9.42B | |
+21.66% | 7.67B | |
+10.61% | 6.05B | |
-1.54% | 4.45B | |
-12.98% | 3.98B | |
-3.37% | 3.66B |
- Stock Market
- Equities
- A092730 Stock
- News NeoPharm CO., LTD.
- Tranche Update on Neopharm Co Ltd's Equity Buyback Plan announced on February 10, 2014.